does blue cross blue shield pay for glp 1 of Michigan won't cover popular weight-loss drugs Anthem Blue Cross Blue Shield

The researcher believes that it may be related to the patients habit of excessive intake ( BN can reduce body weight, inhibit inflammatory reactions, directly be excreted by the kidney, and have fewer adverse reactions

BMO Capital analyst Evan Seigerman said Lillys dominance in the GLP-1 space continues to deepen, with physicians and patients increasingly favouring its drugs

People with diabetes have had a hard time getting ahold of their medications because of the shortages, with some rationing their drugs to cope with the lack of supply, NPR reported

Plaintiffs allege the drug has been linked to severe gastrointestinal injuries, including gastroparesis, as well as vision loss and other complications that have disrupted patients health, nutrition, employment, and daily functioning

doi:10.2337/dci24-0003 9

Beyond Novo and Eli Lilly, companies such as Boehringer Ingelhium, Pfizer, Roche, AstraZeneca, Regor therapeutics, Viking Therapeutics, Amgen, BioAge Labs, Gan & Lee Pharmaceuticals, Sun Pharma, Innovent Biologics, Aphaia Pharma, Vertex Pharmaceuticals , and others are entering the space, fueling new innovations in GLP-1 therapies, combination therapies, and next-gen metabolic treatments